Guidelines on the diagnosis and management of chronic lymphocytic leukaemia
Authors:
- T IllidgeTIT Illidge
- Guidelines Working Group of the UK CLL Forum. British Committee for Standards in HaematologyGHGuidelines Working Group of the UK CLL Forum. British Committee for Standards in Haematology
Open Access
- 1 April 2004
- journal article
- guideline
- Published by Wiley in British Journal of Haematology
- Vol. 125 (3) , 294-317
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemiaBlood, 2004
- Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemiaCancer, 2003
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003
- The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progressionBlood, 2003
- Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)Blood, 2002
- Genetic susceptibility to chronic lymphocytic leukemiaLeukemia, 2002
- Role of Splenectomy in Chronic Lymphocytic LeukemiaJournal of the American College of Surgeons, 1997
- Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimesBritish Journal of Haematology, 1994
- Splenectomy for hypersplenism in chronic lymphocytic leukaemia and malignant non-Hodgkin's lymphomaBritish Journal of Surgery, 1990
- Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survivalBritish Journal of Haematology, 1989